EGFR and non-small cell lung carcinoma: These observations highlight that oncogene dependence in EGFR-mutant NSCLC is determined not only by the presence of an activating mutation but also by the relative expression stoichiometry and functional protein interactions of the putative oncogenic driver (fig.